AZD3965
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD3965, covering 2022-04-11 to 2022-04-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial of AZD3965 in Patients With Advanced Cancer [Phase 1]